GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Primo Nutraceuticals Inc (OTCPK:BUGVF) » Definitions » ROIC %

Primo Nutraceuticals (Primo Nutraceuticals) ROIC % : -27.28% (As of Apr. 2020)


View and export this data going back to 2019. Start your Free Trial

What is Primo Nutraceuticals ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Primo Nutraceuticals's annualized return on invested capital (ROIC %) for the quarter that ended in Apr. 2020 was -27.28%.

As of today (2024-06-25), Primo Nutraceuticals's WACC % is 0.00%. Primo Nutraceuticals's ROIC % is 0.00% (calculated using TTM income statement data). Primo Nutraceuticals earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Primo Nutraceuticals ROIC % Historical Data

The historical data trend for Primo Nutraceuticals's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Primo Nutraceuticals ROIC % Chart

Primo Nutraceuticals Annual Data
Trend Jul16 Jul17 Jul18 Jul19
ROIC %
- - -35.87 -54.99

Primo Nutraceuticals Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.48 -92.40 -59.83 -5.26 -27.28

Competitive Comparison of Primo Nutraceuticals's ROIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Primo Nutraceuticals's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Primo Nutraceuticals's ROIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Primo Nutraceuticals's ROIC % distribution charts can be found below:

* The bar in red indicates where Primo Nutraceuticals's ROIC % falls into.



Primo Nutraceuticals ROIC % Calculation

Primo Nutraceuticals's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Jul. 2019 is calculated as:

ROIC % (A: Jul. 2019 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jul. 2018 ) + Invested Capital (A: Jul. 2019 ))/ count )
=-1.068 * ( 1 - 0% )/( (1.589 + 2.295)/ 2 )
=-1.068/1.942
=-54.99 %

where

Primo Nutraceuticals's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Apr. 2020 is calculated as:

ROIC % (Q: Apr. 2020 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2020 ) + Invested Capital (Q: Apr. 2020 ))/ count )
=-0.748 * ( 1 - 0% )/( (2.895 + 2.588)/ 2 )
=-0.748/2.7415
=-27.28 %

where

Note: The Operating Income data used here is four times the quarterly (Apr. 2020) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Primo Nutraceuticals  (OTCPK:BUGVF) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Primo Nutraceuticals's WACC % is 0.00%. Primo Nutraceuticals's ROIC % is 0.00% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Primo Nutraceuticals ROIC % Related Terms

Thank you for viewing the detailed overview of Primo Nutraceuticals's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Primo Nutraceuticals (Primo Nutraceuticals) Business Description

Traded in Other Exchanges
N/A
Address
890 West Pender Street, Suite 440, Vancouver, BC, CAN, V6C 1J9
Primo Nutraceuticals Inc is engaged in the production, processing, retail and branding of cannabis and cannabis-related products. The company offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors.